Peter Wimmer

1.4k total citations
47 papers, 1.1k citations indexed

About

Peter Wimmer is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Peter Wimmer has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 17 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Peter Wimmer's work include Virus-based gene therapy research (16 papers), interferon and immune responses (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Peter Wimmer is often cited by papers focused on Virus-based gene therapy research (16 papers), interferon and immune responses (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Peter Wimmer collaborates with scholars based in Germany, Austria and Canada. Peter Wimmer's co-authors include Sabrina Schreiner, Thomas Dobner, Peter Groitl, Paola Blanchette, Roger D. Everett, Philip E. Branton, Hüseyin Sirma, Andreas Mund, Sarah Kinkley and Claudia Schmidt and has published in prestigious journals such as Nucleic Acids Research, Oncogene and Journal of Virology.

In The Last Decade

Peter Wimmer

45 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Wimmer Germany 18 610 536 321 283 225 47 1.1k
Franck Halary France 22 375 0.6× 168 0.3× 1.2k 3.7× 284 1.0× 382 1.7× 44 1.8k
Farbod Babrzadeh United States 17 414 0.7× 139 0.3× 329 1.0× 106 0.4× 334 1.5× 26 1.4k
Mengxi Jiang United States 18 494 0.8× 271 0.5× 98 0.3× 691 2.4× 129 0.6× 27 1.3k
Leighton Clancy Australia 19 208 0.3× 427 0.8× 311 1.0× 653 2.3× 702 3.1× 40 1.5k
Nir Drayman United States 14 287 0.5× 85 0.2× 175 0.5× 160 0.6× 154 0.7× 22 649
Scott H. Robbins United States 25 291 0.5× 124 0.2× 2.1k 6.6× 484 1.7× 427 1.9× 44 2.6k
Michael Nevels Germany 26 973 1.6× 571 1.1× 842 2.6× 539 1.9× 1.2k 5.3× 47 2.3k
Joanna M. Gilbert United States 20 312 0.5× 207 0.4× 163 0.5× 182 0.6× 304 1.4× 23 1.1k
Paul G. Cantalupo United States 20 460 0.8× 145 0.3× 130 0.4× 589 2.1× 162 0.7× 37 1.3k
Andrew M. Lewis United States 20 344 0.6× 391 0.7× 102 0.3× 490 1.7× 112 0.5× 44 1.0k

Countries citing papers authored by Peter Wimmer

Since Specialization
Citations

This map shows the geographic impact of Peter Wimmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wimmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wimmer more than expected).

Fields of papers citing papers by Peter Wimmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Wimmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wimmer. The network helps show where Peter Wimmer may publish in the future.

Co-authorship network of co-authors of Peter Wimmer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Wimmer. A scholar is included among the top collaborators of Peter Wimmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Wimmer. Peter Wimmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wimmer, Peter, et al.. (2019). Toward harmonizing prospective effectiveness assessment for road safety: Comparing tools in standard test case simulations. Traffic Injury Prevention. 20(sup1). S139–S145. 8 indexed citations
2.
Braun, Jürgen, et al.. (2019). Versorgungssituation von Patienten mit ankylosierender Spondylitis und Psoriasisarthritis in Deutschland. Zeitschrift für Rheumatologie. 78(4). 372–381. 3 indexed citations
3.
Page, Yves, Thomas Helmer, Magdalena Lindman, et al.. (2015). A comprehensive and harmonized method for assessing the effectiveness of advanced driver assistance systems by virtual simulation: The P.E.A.R.S. 1–12. 13 indexed citations
4.
Manger, Bernhard, Falk Hiepe, Peter Wimmer, et al.. (2015). Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study. Clinical and Experimental Gastroenterology. 8. 205–205. 12 indexed citations
5.
Deuse, T., Christoph Bara, Markus J. Barten, et al.. (2015). The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation. Contemporary Clinical Trials. 45(Pt B). 356–363. 10 indexed citations
6.
Wimmer, Peter, et al.. (2015). Fast Calculating Surrogate Models for Leg and Head Impact in Vehicle–Pedestrian Collision Simulations. Traffic Injury Prevention. 16(sup1). S84–S90. 6 indexed citations
7.
Wimmer, Peter, Paola Blanchette, Peter Groitl, et al.. (2015). PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53. Oncogene. 35(1). 69–82. 18 indexed citations
8.
9.
Zschiedrich, Stefan, Klemens Budde, Jens Nürnberger, et al.. (2015). Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation. 31(2). 284–289. 8 indexed citations
10.
11.
Schreiner, Sabrina, Mandy Glaß, Peter Groitl, et al.. (2013). Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes. Nucleic Acids Research. 41(6). 3532–3550. 77 indexed citations
12.
Schreiner, Sabrina, Sarah Kinkley, Andreas Mund, et al.. (2013). SPOC1-Mediated Antiviral Host Cell Response Is Antagonized Early in Human Adenovirus Type 5 Infection. PLoS Pathogens. 9(11). e1003775–e1003775. 49 indexed citations
13.
Schreiner, Sabrina, Ruben Martinez, Peter Groitl, et al.. (2012). Transcriptional Activation of the Adenoviral Genome Is Mediated by Capsid Protein VI. PLoS Pathogens. 8(2). e1002549–e1002549. 56 indexed citations
14.
Wimmer, Peter, Paola Blanchette, Sabrina Schreiner, et al.. (2012). Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein. Oncogene. 32(13). 1626–1637. 36 indexed citations
15.
Schreiner, Sabrina, Peter Wimmer, & Thomas Dobner. (2012). Adenovirus Degradation of Cellular Proteins. Future Microbiology. 7(2). 211–225. 43 indexed citations
16.
Perkhofer, Susanne, Michaela M. Hell, Burkhard Gustorff, et al.. (2011). Austrian Clinical Practice with Anidulafungin in 2008: A Multicenter Survey. Journal of Chemotherapy. 23(5). 285–289. 1 indexed citations
17.
Wimmer, Peter, Birgitt Täuber, Thilo Spruß, & Thomas Dobner. (2010). Adenovirus type 5 early encoded proteins of the E1 and E4 regions induce oncogenic transformation of primary rabbit cells. Journal of General Virology. 91(7). 1828–1833. 3 indexed citations
18.
Schindler, Michael, Devi Rajan, Carina Banning, et al.. (2010). Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue. Retrovirology. 7(1). 1–1. 68 indexed citations
19.
Wimmer, Peter, Sabrina Schreiner, Roger D. Everett, et al.. (2010). SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML. Oncogene. 29(40). 5511–5522. 46 indexed citations
20.
Wimmer, Peter, et al.. (2003). Dissipation of vortices in CFD‐simulations. PAMM. 3(1). 344–345. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franck Halary Breakdown of academic impact, for papers by Farbod Babrzadeh Breakdown of academic impact, for papers by Mengxi Jiang Breakdown of academic impact, for papers by Leighton Clancy Breakdown of academic impact, for papers by Nir Drayman Breakdown of academic impact, for papers by Scott H. Robbins Breakdown of academic impact, for papers by Michael Nevels Breakdown of academic impact, for papers by Joanna M. Gilbert Breakdown of academic impact, for papers by Paul G. Cantalupo Breakdown of academic impact, for papers by Andrew M. Lewis
Rankless by CCL
2026